Related references
Note: Only part of the references are listed.Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
Y. Xu et al.
ANNALS OF ONCOLOGY (2013)
Mutant KRAS Codon 12 and 13 Alleles in Patients With Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to Panitumumab
Marc Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression
Yan-Qiu Wang et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Alberto Bardelli et al.
CANCER DISCOVERY (2013)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H. J. Schmoll et al.
ANNALS OF ONCOLOGY (2012)
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
Olafur A. Stefansson et al.
EPIGENETICS (2012)
A DNA methylation fingerprint of 1628 human samples
Agustin F. Fernandez et al.
GENOME RESEARCH (2012)
Global burden of cancer: opportunities for prevention
Ahmedin Jemal
LANCET (2012)
DNA methylation profiling in the clinic: applications and challenges
Holger Heyn et al.
NATURE REVIEWS GENETICS (2012)
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
V. Davalos et al.
ONCOGENE (2012)
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs
Apichart Atipairin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Epigenetic Alteration of PRKCDBP in Colorectal Cancers and Its Implication in Tumor Cell Resistance to TNFα-Induced Apoptosis
Jin-Hee Lee et al.
CLINICAL CANCER RESEARCH (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function
Kerrie-Ann McMahon et al.
EMBO JOURNAL (2009)
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer
Anna Martinez-Cardus et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Genome-wide DNA methylation profiling using Infinium (R) assay
Marina Bibikova et al.
EPIGENOMICS (2009)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation
S Zöchbauer-Müller et al.
ONCOGENE (2005)
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
M Moroni et al.
LANCET ONCOLOGY (2005)
The staging of colorectal cancer: 2004 and beyond
CC Compton et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2004)
Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines
S Arnould et al.
EUROPEAN JOURNAL OF CANCER (2003)
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
M Esteller et al.
HUMAN MOLECULAR GENETICS (2001)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
